Effient is a prescription medication used to prevent blood clots in adults who have had a recent heart attack or stroke, or who have established peripheral arterial disease or diabetes [1]. It is a prodrug that is converted in the body to its active metabolite, which inhibits platelet aggregation [1].
How does Effient work?
Effient is an antiplatelet medication. Platelets are small blood cells that clump together to form clots. Effient works by irreversibly blocking the P2Y12 adenosine diphosphate (ADP) receptor on the surface of platelets [1]. This action prevents ADP from binding to the receptor, which in turn reduces platelet activation and aggregation, thereby decreasing the risk of blood clot formation [1].
What is the active ingredient in Effient?
The active ingredient in Effient is prasugrel [1].
When does Effient's patent expire?
The patent expiry for Effient is a complex issue with multiple patents involved. According to DrugPatentWatch.com, the earliest patent for prasugrel expired in July 2023 [2]. However, there may be other patents covering different aspects of the drug, such as formulations or methods of use, that extend protection [2].
Who makes Effient?
Effient was developed by Daiichi Sankyo and Ube Industries [1]. Eli Lilly and Company is also involved in its marketing and distribution [1].
What are the risks associated with taking Effient?
The most serious risk associated with Effient is bleeding. This can occur anywhere in the body and can be life-threatening [1]. Patients taking Effient are also at an increased risk of bruising and prolonged bleeding from cuts [1]. Other potential risks include stroke, transient ischemic attack, and allergic reactions [1].
What are Effient's alternatives?
Other antiplatelet medications are available, including clopidogrel (Plavix) and ticagrelor (Brilinta) [3]. The choice of medication depends on individual patient factors, including medical history, other medications, and physician recommendation [3].
What are the side effects of Effient?
Common side effects of Effient include bruising and bleeding, such as nosebleeds or bleeding gums [1]. Other possible side effects include rash, shortness of breath, and gastrointestinal upset [1].
How does Effient compare to Plavix?
Both Effient (prasugrel) and Plavix (clopidogrel) are P2Y12 inhibitors used to prevent blood clots. Clinical trials have shown that Effient may be more effective than clopidogrel in reducing cardiovascular events in certain patient populations, such as those undergoing percutaneous coronary intervention (PCI) [3]. However, Effient may also be associated with a higher risk of bleeding compared to clopidogrel in some studies [3].
What is the typical dosage of Effient?
The typical starting dose of Effient is 60 mg once daily [1]. After the initial loading dose, the maintenance dose is usually 10 mg once daily [1]. Dosage adjustments may be necessary based on individual patient factors and medical conditions [1].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/drug/prasugrel
[3] https://www.drugpatentwatch.com/drug/clopidogrel